Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Furoate AM vs PM Dosing in Asthma
NCT01808339Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone in asthma, sponsored by GSK. Started Mar 2013; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01808339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01808339.